Study on postprandial glycemic control of fiber-multivitamin combination in type 2 diabetes (Acute effect)

Phase 1

• Conditions: Diabetes mellitus (DM) is public health worldwide. Some 425 million people worldwide, or 8.8% of adults 20- 79 years, are estimated to have diabetes. Also the situation of prevalence DM in Thailand inc; fiber- multivitamin combination, glycemic control, insulin response, type 2 diabetes (T2DM).

• Registration Number: TCTR20180617001
• Lead Sponsor: nicity Science

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2018-06-17
• Study Completion: 2019-01-01
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Pending (Not yet recruiting)
• Sex: All
• Target Recruitment: 15

Inclusion Criteria

- BMI 18.5-30 kg/m2
- Thai nationality
- Diagnosis T2DM and fasting blood glucose lessthan 180 mg/dl
- Concomitant therapy only stable oral hypoglycemic drugs such as metformin/Glucophage
-Stable body weight for at least 6 mo

Exclusion Criteria

-Pregnant or lactating females
-Persons with known allergies to any ingredients in either the active or placebo study compounds will be also excluded.
-People who habitually used a dietary fiber supplement will be also excluded.
-Following, or recently followed, a diet plan or supplement or medication use known to affect the trial
- Persons with gastrointestinal disease, renal disease, liver disease, thyroid disease, concomitant therapy insulin, and also severe health condition (e.g., cancer, CVD)
- participating in any vigorous exercise program

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
fasting and postprandial glycemic response 2 days the automated (enzymatic) method

Secondary Outcome Measures

Name	Time	Method
fasting and postprandial insulin response 2 days Chemiluminescence immunoassay (CLIA)